Pharmaceutical Research

SJR Rank #6,058H-index: 241SJR: 0.873Best quartile: Q1APC: US$4,690
Journal website: aims, scope and author guidelines
Publisher

Springer

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Organic ChemistryQ1
  • Pharmaceutical ScienceQ1
  • BiotechnologyQ2
  • Molecular MedicineQ2
  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Advanced Drug Delivery SystemsDrug Solubulity and Delivery SystemsAdvancements in Transdermal Drug DeliveryNanoparticle-Based Drug DeliveryDrug Transport and Resistance MechanismsRNA Interference and Gene DeliveryInhalation and Respiratory Drug DeliveryProtein purification and stabilityPharmacogenetics and Drug MetabolismLipid Membrane Structure and Behavior

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025070140210280

Detailed Information

ISSN

0724-8741, 1573-904X

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

4.02

References per Document

59.08

Coverage

1984-2026

Scope

Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to: -(pre)formulation engineering and processing- computational biopharmaceutics- drug delivery and targeting- molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)- pharmacokinetics, pharmacodynamics and pharmacogenetics. Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.

Metrics from SCImago Journal Rank 2025. View on SCImago